RxAll, launched by Adebayo Alonge and Amy Kao in 2016, aims to stop counterfeit medicines in Africa. Their flagship product, the RxScanner, utilizes AI and spectroscopy to identify counterfeit pills, enhancing the safety of medications. Beyond this, RxAll has expanded its services to include drug procurement, demand prediction via point-of-sale systems, and financing options for independent pharmacies. They've doubled their pharmacy network to over 5,000 and significantly reduced counterfeit drug presence, collaborating with various government bodies to promote proactive regulation and public health awareness.
"The friction really is around understanding what products are low quality, understanding what products are in demand, and getting access to financing to purchase quality products."
"In the past year, RxAll has seen its network of pharmacies more than double, reaching 5,000-plus locations, largely in Nigeria, Kenya, and Uganda."
"Ideally, we work ourselves out of a job," she says, indicating that the goal is to eliminate the counterfeit medication problem.
"[RxAll's goal is] to enable these public partners to take a more proactive approach and address counterfeiting and drug safety before tainted products get to patients."
Collection
[
|
...
]